Low skeletal muscle mass is associated with increased hospital expenditure in patients undergoing cancer surgery of the alimentary tract

Autor: Jan N. M. IJzermans, Stefan Buettner, Marcia P. Gaspersz, Jeroen L.A. van Vugt, Ron W. F. de Bruin, N. Bossche, Stef Levolger, Cornelis Verhoef, Casper H. C. van Eijck, Mustafa Suker, Bas Groot Koerkamp, Robert R. J. Coebergh van den Braak
Přispěvatelé: Surgery, Erasmus MC other
Jazyk: angličtina
Rok vydání: 2017
Předmět:
Male
Colorectal cancer
Cancer Treatment
lcsh:Medicine
Digestive System Neoplasms
Cholangiocarcinoma
0302 clinical medicine
Surgical oncology
Adenocarcinomas
Periampullary cancer
Medicine and Health Sciences
030212 general & internal medicine
Hospital Costs
lcsh:Science
Wasting
Musculoskeletal System
Multidisciplinary
Muscles
Liver Diseases
Organ Size
Middle Aged
people.cause_of_death
Hospitals
medicine.anatomical_structure
Surgical Oncology
Treatment Outcome
Oncology
030220 oncology & carcinogenesis
Hepatocellular carcinoma
Female
medicine.symptom
Anatomy
Research Article
Hepatic Resection
Clinical Oncology
medicine.medical_specialty
Surgical and Invasive Medical Procedures
Gastroenterology and Hepatology
Carcinomas
03 medical and health sciences
Digestive System Procedures
SDG 3 - Good Health and Well-being
Internal medicine
Gastrointestinal Tumors
medicine
Humans
Muscle
Skeletal

Aged
Surgical Resection
business.industry
lcsh:R
Cancer
Skeletal muscle
Biology and Life Sciences
Cancers and Neoplasms
Hepatocellular Carcinoma
medicine.disease
Surgery
Health Care
Skeletal Muscles
Health Care Facilities
Sarcopenia
lcsh:Q
Clinical Medicine
business
people
Zdroj: PLoS ONE, Vol 12, Iss 10, p e0186547 (2017)
PLoS ONE
PLoS One (online), 12(10):e0186547. Public Library of Science
ISSN: 1932-6203
Popis: Background: Low skeletal muscle mass is associated with poor postoperative outcomes in cancer patients. Furthermore, it is associated with increased healthcare costs in the United States. We investigated its effect on hospital expenditure in a Western-European healthcare system, with universal access. Methods: Skeletal muscle mass (assessed on CT) and costs were obtained for patients who underwent curative-intent abdominal cancer surgery. Low skeletal muscle mass was defined based on pre-established cut-offs. The relationship between low skeletal muscle mass and hospital costs was assessed using linear regression analysis and Mann-Whitney U-tests. Results: 452 patients were included (median age 65, 61.5% males). Patients underwent surgery for colorectal cancer (38.9%), colorectal liver metastases (27.4%), primary liver tumours (23.2%), and pancreatic/periampullary cancer (10.4%). In total, 45.6% had sarcopenia. Median costs were €2,183 higher in patients with low compared with patients with high skeletal muscle mass (€17,144 versus €14,961; P
Databáze: OpenAIRE